These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8139134)

  • 1. Erythrocyte sodium cannot predict hypotensive effects of calcium channel blockers.
    Oshima T; Matsuura H; Ozono R; Ishida-Kainouchi M; Ishida T; Ishibashi K; Watanabe M; Okura Y; Kanbe M; Kajiyama G
    Nihon Jinzo Gakkai Shi; 1993 Nov; 35(11):1227-31. PubMed ID: 8139134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive effect of a new calcium channel blocker, FK 235, in essential hypertension.
    Mizuno K; Hashimoto S; Yabe R; Kunii N; Niimura S; Tani M; Watari H; Fukuchi S
    Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):3-15. PubMed ID: 3520729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nilvadipine: profile of a new calcium antagonist. An overview.
    Rosenthal J
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S92-107. PubMed ID: 7898101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic hemorheological effects of the calcium antagonist nilvadipine in essential hypertension.
    Tsuda Y; Satoh K; Kitadai M; Izumi Y; Takahashi T
    Arzneimittelforschung; 1997 Aug; 47(8):900-4. PubMed ID: 9296274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nisoldipine on sympathetic activity, the renin-angiotensin-aldosterone system, and water-sodium-calcium metabolism in patients with essential hypertension.
    Iimura O; Kikuchi K; Shimamoto K; Nozawa A; Hasegawa R; Homma C; Komura H; Kobayakawa H
    Arzneimittelforschung; 1989 Jun; 39(6):710-4. PubMed ID: 2775339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive therapy with the long-acting calcium antagonist nitrendipine.
    Müller FB; Bolli P; Erne P; Block LH; Kiowski W; Bühler FR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1073-6. PubMed ID: 6085370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of amlodipine on urinary sodium excretion, renin-angiotensin-aldosterone system, atrial natriuretic peptide and blood pressure in essential hypertension.
    Cappuccio FP; Markandu ND; Sagnella GA; Singer DR; Buckley MG; Miller MA; MacGregor GA
    J Hum Hypertens; 1991 Apr; 5(2):115-9. PubMed ID: 1830107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of regression of vascular structural changes and its relation to cytosolic free calcium in hypertensives after nilvadipine treatment.
    Ueno H; Takata M; Oh-hashi S; Tomoda F; Yasumoto K; Inoue H
    J Hum Hypertens; 1995 Sep; 9(9):735-9. PubMed ID: 8551487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics of nilvadipine, a new dihydropyridine-type calcium antagonist.
    Honerjäger P; Seibel K
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S15-21. PubMed ID: 1283184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nilvadipine in hypertension with renal dysfunction.
    Berger HH; Albert FW
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S73-9. PubMed ID: 1283194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
    Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
    Leonetti G;
    Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship of the renin-angiotensin-aldosterone system with auricular natriuretic factor in its response to the action of thiazide diuretics and to nifedipine, a sustained-release calcium antagonist].
    Ocón J; Mora-Macià J; Castellet R; del Río G
    Med Clin (Barc); 1994 Jan; 102(2):41-5. PubMed ID: 8133694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive and humoral effects of verapamil and nifedipine in essential hypertension.
    Muiesan G; Agabiti-Rosei E; Castellano M; Alicandri CL; Corea L; Fariello R; Beschi M; Romanelli G
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S325-9. PubMed ID: 6184562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nifedipine on blood pressure and on intracellular calcium in arterial hypertension.
    Zidek W; Losse H; Vetter H
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S303-5. PubMed ID: 6184558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 24-hour blood pressure control after single daily doses of nivaldipine in patients with essential hypertension.
    Lossnitzer K; Huber HJ; Kuchlbauer R; Quitzdorff G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S35-42. PubMed ID: 1283187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking T-type Ca2+ channels with efonidipine decreased plasma aldosterone concentration in healthy volunteers.
    Okayama S; Imagawa K; Naya N; Iwama H; Somekawa S; Kawata H; Horii M; Nakajima T; Uemura S; Saito Y
    Hypertens Res; 2006 Jul; 29(7):493-7. PubMed ID: 17044661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The specificity of the hypotensive effect of calcium antagonists in hypertension].
    Ivleva AIa; Kobalava ZhD; Antiia ID; Krasnobaeva GM; Iartsev VE; Lepakhin VK; Moiseev VS
    Ter Arkh; 1991; 63(9):97-100. PubMed ID: 1759235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arterial hypertension caused by low renin: comparison of the calcium antagonist nifedipine and the ACE-inhibitor enalapril as to antihypertensive efficacy].
    Andronico G; Carone MB; Mulè G; Mangano MT; Cerasola G
    Boll Soc Ital Biol Sper; 1990 Dec; 66(12):1161-4. PubMed ID: 2100527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive and hormonal effects of PN 200-110, a new calcium-channel blocker, in essential hypertension.
    Swartz SL
    J Clin Hypertens; 1987 Dec; 3(4):463-9. PubMed ID: 2969038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.